| Document and Entity Information - USD ($) | 3 Months Ended | |
| Feb. 29, 2016 | Apr. 12, 2016 | |
| Document And Entity Information | ||
| Entity Registrant Name | Opulent Acquisition, Inc. | |
| Entity Central Index Key | 1,634,291 | |
| Document Type | 10-Q | |
| Document Period End Date | Feb. 29, 2016 | |
| Amendment Flag | false | |
| Current Fiscal Year End Date | --11-30 | |
| Entity Well Known Seasoned Issuer | No | |
| Entity Voluntary Filers | No | |
| Entity Current Reporting Status | Yes | |
| Entity Filer Category | Smaller Reporting Company | |
| Entity Public Float | $ 0 | |
| Entity Common Stock Shares Outstanding | 20,000,000 | |
| Document Fiscal Period Focus | Q1 | |
| Document Fiscal Year Focus | 2,016 |
| BALANCE SHEETS - USD ($) | Feb. 29, 2016 | Nov. 30, 2015 |
| Current Assets | ||
| Total Assets | ||
| Current Liabilities | ||
| Accrued Expenses | $ 3,500 | $ 3,446 |
| Total Current Liabilities | 3,500 | 3,446 |
| Total Liabilities | $ 3,500 | $ 3,446 |
| Stockholders' Deficit | ||
| Preferred Stock ($.0001 par value, 20,000,000 authorized; none issued and outstanding as of February 29, 2016 and November 30, 2015) | ||
| Common stock ($0.0001 par value, 500,000,000 shares authorized; 20,000,000 shares issued and outstanding as of February 29, 2016 and November 30, 2015) | $ 2,000 | $ 2,000 |
| Additional Paid In Capital | 10,894 | 6,198 |
| Accumulated Deficit | (16,394) | (11,644) |
| Total Stockholders' Deficit | $ (3,500) | $ (3,446) |
| Total Liabilities & Stockholders' Deficit |
| BALANCE SHEETS (Parenthetical) - $ / shares | Feb. 29, 2016 | Nov. 30, 2015 |
| StockholdersEquity | ||
| Preferred Stock Par Or Stated Value Per Share | $ 0.0001 | $ 0.0001 |
| Preferred Stock Shares Authorized | 20,000,000 | 20,000,000 |
| Preferred Stock Shares Issued | 0 | 0 |
| Preferred Stock Shares Outstanding | 0 | 0 |
| Common Stock Par Or Stated Value Per Share | $ 0.0001 | $ .0001 |
| Common Stock Shares Authorized | 500,000,000 | 500,000,000 |
| Common Stock Shares Issued | 20,000,000 | 20,000,000 |
| Common Stock Shares Outstanding | 20,000,000 | 20,000,000 |
| STATEMENTS OF OPERATIONS - USD ($) | 3 Months Ended | |
| Feb. 29, 2016 | Feb. 28, 2015 | |
| Income Statement [Abstract] | ||
| Professional Fees | $ 4,750 | $ 1,500 |
| Total Operating Expenses | 4,750 | 1,500 |
| Net Loss | $ (4,750) | $ (1,500) |
| Basic and Diluted net loss per share of common stock | $ 0 | $ 0 |
| Weighted Average Number of Common Shares Outstanding-Basic and Diluted | 20,000,000 | 20,000,000 |
| STATEMENT OF CASH FLOWS - USD ($) | 3 Months Ended | |
| Feb. 29, 2016 | Feb. 28, 2015 | |
| CASH FLOWS FROM OPERATING ACTIVITIES | ||
| Net loss | $ (4,750) | $ (1,500) |
| Expenses contributed to capital | $ 4,696 | 2,648 |
| Share based expenses | ||
| Accrued Expenses | $ 54 | $ (1,148) |
| Net cash used in operating activities | ||
| Increase (Decrease) in cash | ||
| Ending Cash Balance | ||
| Interest paid | ||
| Income taxes paid | ||
| ORGANIZATION AND DESCRIPTION OF BUSINESS | 3 Months Ended |
| Feb. 29, 2016 | |
| Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
| Organization and Description of Business | Note 1 Organization and Description of Business Opulent Acquisition, Inc. (the Company) was incorporated under the laws of the State of Delaware on November 25, 2014. The Company intended to serve as a vehicle to affect an asset acquisition, merger, exchange of capital stock or other business combination with a domestic or foreign business. The Company has elected November 30th as its year end. On January 14, 2016, Mr. Jeffrey DeNunzio, the former sole shareholder of Opulent Acquisition, Inc., sold 20,000,000 shares of common stock to iHealthcare, Inc. Following the closing of the share purchase transaction, iHealthcare, Inc. owns a 100% interest in the issued and outstanding shares of our common stock. iHealthcare, Inc. is the controlling shareholder of Opulent Acquisition, Inc. As of February 29, 2016 the Company had not yet commenced any operations. On January 14, 2016, Mr. Jeffrey DeNunzio resigned as Chief Executive Officer, Chief Financial Officer, President, Secretary, Treasurer and Director of Opulent Acquisition, Inc. On January 14, 2016, Mr. Noel Mijares was appointed as Chairman of the Board of Directors, Chief Executive Officer, and President. On January 14, 2016, Mr. David A. Bingaman was appointed as Chief Operating Officer, Vice President, and Secretary. |
| SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES | 3 Months Ended |
| Feb. 29, 2016 | |
| Accounting Policies [Abstract] | |
| Significant Accounting Policies | Note 2 Summary of Significant Accounting Policies Basis of Presentation The accompanying unaudited financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America for interim financial information and with the instructions to Form 10-Q and Regulation S-X. Accordingly, these financial statements do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all adjustments considered necessary for a fair presentation have been included and such adjustments are of a normal recurring nature. These financial statements should be read in conjunction with the financial statements for the year ended November 30, 2015 and notes thereto. The results of operations for the three month period ended February 29, 2016 are not necessarily indicative of the results for the full fiscal year ending November 30, 2016. |
| GOING CONCERN | 3 Months Ended |
| Feb. 29, 2016 | |
| Going Concern | |
| Going Concern | Note 3 Going Concern The Companys financial statements are prepared using accounting principles generally accepted in the United States of America applicable to a going concern that contemplates the realization of assets and liquidation of liabilities in the normal course of business. The Company demonstrates adverse conditions that raise substantial doubt about the Company's ability to continue as a going concern for one year following the issuance of these financial statements. These adverse conditions are negative financial trends, specifically operating loss, working capital deficiency, negative cash flow from operating activities, and other adverse key financial ratios. The Company has not established any source of revenue to cover its operating costs. Management plans to fund operating expenses with related party contributions to capital. There is no assurance that management's plan will be successful. The financial statements do not include any adjustments relating to the recoverability and classification of recorded assets, or the amounts and classification of liabilities that might be necessary in the event that the Company cannot continue as a going concern. |
| ACCRUED EXPENSES | 3 Months Ended |
| Feb. 29, 2016 | |
| Payables and Accruals [Abstract] | |
| ACCRUED EXPENSES | Note 4 Accrued Expenses Accrued expenses totaled $3,500 and $3,446 at February 29, 2016 and November 30, 2015, respectively and consisted solely of professional fees and general and administrative expenses. |
| RELATED PARTIES DISCLOSURE | 3 Months Ended |
| Feb. 29, 2016 | |
| Related Party Transactions [Abstract] | |
| Related Party Transactions | Note 5 Related-Party Transactions Common stock On January 14, 2016, Mr. Jeffrey DeNunzio, the former sole shareholder of Opulent Acquisition, Inc., sold 20,000,000 shares of common stock to iHealthcare, Inc. Following the closing of the share purchase transaction, iHealthcare, Inc. owns a 100% interest in the issued and outstanding shares of our common stock. iHealthcare, Inc. is the controlling shareholder of Opulent Acquisition, Inc. Additional paid in capital During the three month period ending February 29, 2016, our former sole officer/director/shareholder contributed additional paid in capital in the amount of $4,696 to fund operating expenses. |
| NOTE 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) | 3 Months Ended |
| Feb. 29, 2016 | |
| Accounting Policies [Abstract] | |
| Basis of Presentation | Basis of Presentation The accompanying unaudited financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America for interim financial information and with the instructions to Form 10-Q and Regulation S-X. Accordingly, these financial statements do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all adjustments considered necessary for a fair presentation have been included and such adjustments are of a normal recurring nature. These financial statements should be read in conjunction with the financial statements for the year ended November 30, 2015 and notes thereto. The results of operations for the three month period ended February 29, 2016 are not necessarily indicative of the results for the full fiscal year ending November 30, 2016. |
